| Original language | English (US) |
|---|---|
| Pages (from-to) | 1737-1738 |
| Number of pages | 2 |
| Journal | JAMA Internal Medicine |
| Volume | 179 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2019 |
| Externally published | Yes |
ASJC Scopus subject areas
- Internal Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: JAMA Internal Medicine, Vol. 179, No. 12, 12.2019, p. 1737-1738.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Safety of the Use of Radioactive Iodine in Patients with Hyperthyroidism
AU - Peacock, Justin G.
AU - Clemenshaw, Michael N.
AU - Banks, Kevin P.
N1 - Funding Information: Author Affiliations: Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (Kitahara, Berrington de González); Hirosoft International, Eureka, California (Preston). Corresponding Author: Cari M. Kitahara, PhD, MHS, Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr, Rm 7E-536, Bethesda, MD 20892 (kitaharac@mail.nih.gov). Conflict of Interest Disclosures: None reported. Funding Information: Author Affiliations: Department of Neurology, University of Michigan, Ann Arbor (Burke); Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan (Burke, Langa); Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor (Burke, Langa); Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor (Langa); Institute for Social Research, University of Michigan, Ann Arbor (Langa); Institute of Gerontology, University of Michigan, Ann Arbor (Langa). Corresponding Author: James F. Burke, MD, MS, Department of Neurology, University of Michigan, 2800 Plymouth Rd, Bldg 14, Room G105, Ann Arbor, MI 48109 (jamesbur@umich.edu). Conflict of Interest Disclosures: Dr Langa reports receiving grants from the National Institute on Aging of the National Institutes of Health and from the Alzheimer’s Association. No other disclosures were reported. 1. Langa KM, Burke JF. Preclinical Alzheimer disease: early diagnosis or overdiagnosis? JAMA Intern Med. 2019;179(9):1161-1162. doi:10.1001/ jamainternmed.2019.2629 2. Rabinovici GD, Gatsonis C, Apgar C, et al. Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA. 2019;321(13):1286-1294. doi:10.1001/jama.2019.2000 3. Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev. 2006;(1):CD005593. doi:10.1002/14651858.CD005593
PY - 2019/12
Y1 - 2019/12
UR - http://www.scopus.com/inward/record.url?scp=85075778648&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075778648&partnerID=8YFLogxK
U2 - 10.1001/jamainternmed.2019.5117
DO - 10.1001/jamainternmed.2019.5117
M3 - Letter
C2 - 31790527
AN - SCOPUS:85075778648
SN - 2168-6106
VL - 179
SP - 1737
EP - 1738
JO - JAMA Internal Medicine
JF - JAMA Internal Medicine
IS - 12
ER -